LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 17.25 | 5226 | 6239 | 0.8376 | 0.9587 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 17.25 | 5264 | 6239 | 0.8437 | 0.9604 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 17.25 | 6100 | 6239 | 0.9777 | 0.9947 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 17.25 | 6118 | 6239 | 0.9806 | 0.9954 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 3.06 | 17.25 | 279 | 143 | 1.9481 | 1.4882 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 3.06 | 17.25 | 447 | 143 | 3.1212 | 1.9035 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 5.03 | 17.25 | 542 | 273 | 1.9828 | 1.3747 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 5.03 | 17.25 | 723 | 273 | 2.6449 | 1.5527 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 7.01 | 17.25 | 802 | 389 | 2.0591 | 1.3485 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 7.01 | 17.25 | 841 | 389 | 2.1592 | 1.3734 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 8.98 | 17.25 | 927 | 445 | 2.0828 | 1.3387 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 8.98 | 17.25 | 901 | 445 | 2.0244 | 1.3246 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 10.95 | 17.25 | 967 | 471 | 2.0506 | 1.3248 | MN20160310_N02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 10.95 | 17.25 | 926 | 471 | 1.9636 | 1.3037 | MN20160310_N02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | G10 |